What Is Tremfya, and Why Does It Matter? Tremfya (guselkumab) is a lab-made, dual-acting antibody medication that reduces inflammation by targeting the interleukin-23 (IL-23) protein and blocking a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a Healio video exclusive, Jan Wehkamp, MD, PhD, ...
Please provide your email address to receive an email when new articles are posted on . In a video exclusive, Jan Wehkamp, MD, vice president, gastroenterology global disease area leader at Janssen ...
Tremfya is a brand-name medication used to treat moderate to severe ulcerative colitis in adults by targeting a protein that reduces inflammation in the large intestine. Treatment with Tremfya ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved a subcutaneous induction regimen of TREMFYA (guselkumab) for the treatment of adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results